2931.90.22.00/Aromatic Silane Platinum Anti-Cancer Drug/Japan

Aromatic Silane Platinum Anti-Cancer Drug from Japan

Platinum-based chemotherapy agent with aromatic silane ligands, used in cancer treatment protocols. HTS 2931.90.22.00 classification applies to this aromatic organo-inorganic compound containing silicon and platinum linked to carbon.

Duty Rate — Japan → United States

12.5%

Rate breakdown

9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%

Calculate with your customs value Verify classification with AI

Import Tips

• Submit molecular structure diagrams confirming Si-C and Pt coordination bonds

• Comply with cytotoxic drug import protocols including secondary containment packaging

• Verify against List 1 chemicals if platinum complex has precursor potential